BOKUDA TUG'MA YURAK NOMUSLARI BO'LGAN BEMORLARNING EPIDEMIOLOGIK XUSUSIYATLARINI O'RGANISH
##article.subject##:
врожденные пороки сердца (ВПС), возрастные особенности, гендерные особенности, дефекты межжелудочковой перегородки (ДМП); город Баку.##article.abstract##
Adabiyotlarni tahlil qilish shuni ko'rsatadiki, hozirgi vaqtda tug'ma yurak nuqsonlari bolalardagi boshqa rivojlanish nuqsonlari bilan solishtirganda tarqalish bo'yicha etakchi o'rinni egallaydi va bolalar o'limining asosiy sababi bo'lib qolmoqda. Ushbu xulosa bizni yurak nuqsonlari bo'lgan bemorlarning tibbiy va ijtimoiy xususiyatlarini o'rganishga undadi. 0 yoshdan 90 yoshgacha bo'lgan 300 nafar bemor tekshirildi. Asosiy guruhga tug'ma yurak nuqsonlari bo'lgan 150 (50%) bemorlar kiradi: qorincha septal nuqsoni (QSN), bo’lmacha septal nuqson (BSN), ochiq arterioz kanali (OAK) va estrodiol nuqsonlar (ikki yoki uchta yurak nuqsonlari kombinatsiyasi). . Nazorat guruhiga 150 (50%) sog'lom bemorlar kiritilgan. Asosiy guruhdagi bemorlarning 86 nafari (57,33%) uzoq muddatli dori-darmonlarni davolashda bo'lgan, 56 (37,33%) bemorda tug'ma yurak nuqsonlarini jarrohlik yoki invaziv usullar bilan tuzatish amalga oshirilgan, o'lim 5,34% (8 ta holat). Olingan ma'lumotlarga asoslanib, biz ayollar vakillari ko'proq tug'ma yurak nuqsonlaridan aziyat chekadi degan xulosaga kelishimiz mumkin.Shuningdek, tug'ma yurak nuqsonlarini o'z vaqtida tashxislash uchun qizlarning o'ziga xos bo'lmagan shikoyatlariga (nafas qisilishi, yurak urishi kabi) e'tibor qaratishimiz kerak. keksa yoshdagi ayollarning hayot sifatini yaxshilaydi, ayollarda kech, kechiktirilgan tashxis va operatsiyalar foizini kamaytiradi.
Библиографические ссылки
. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation 2022;145:e153-639. Erratum in: Circulation 2022;146:e141. 10.1161/CIR.0000000000001052
Roth G.A., Mensah G.A., Johnson C.O., et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.
World Health Organization. Global Health Estimates 2016: Disease Burden by Cause, Age, Sex, by Country and by Region 2000–2016. https://www.who.int/healthinfo/global_burden_disease/GlobalDALY_method_2000_2016.pdf?ua=1Published, Geneva, 2018. Accessed May 15, 2019.
Hoffman J.I., The global burden of congenital heart disease //Cardiovasc J Afr. 2013 Jun; 24(4): 141–145.doi: 10.5830/CVJA-2013-028
Su Z., Zou Z., Hay S.İ., et al Global, regional, and national time trends in mortality for congenital heart disease, 1990–2019: An age-period-cohort analysis for the Global Burden of Disease 2019 study.EClinicalMedicine. 2022 Jan; 43: 101249. doi: 10.1016/j.eclinm.2021.101249
van der Linde D., Konings E.E., Slager M.A. et al. Birth prevalenceof congenital heart disease worldwide: a systematic review andmeta-analysis //J Am CollCardiol.,2011, 58(21), p.2241–2247. doi: 10.1016/j.jacc.2011.08.025
Benjamin E.J., S.S. Virani , C/W Callaway et al. Heart Disease and Stroke Statistics-2018 Update: a report from the American Heart Association //Circulation, 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31.
M.D Reller 1, Matthew J Strickland, Tiffany Riehle-Colarusso, William T Mahle, Adolfo CorreaPrevalence of congenital heart defects in metropolitan Atlanta, 1998-2005J Pediatr. 2008 Dec;153(6):807-13.DOI: 10.1016/j.jpeds.2008.05.059
.Brida M, Chessa M, Celermajer D, Li W, Geva T, Khairy P, Griselli M, Baumgartner H, Gatzoulis MA. Atrial septal defect in adulthood: a new paradigm for congenital heart disease. Eur Heart J. 2022; 43:2660–2671. doi: 10.1093/eurheartj/ehab646
Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114:1873–1882.
Hrusca A., Cainap S.,Rachisan A.L., et al. Congenital heart defects and associated comorbidities - 5 years of experience //HVM Bioflux,2013, 5(2), p.62–65.
